Cell replacement therapy for type 1 diabetes

被引:39
作者
Efrat, S [1 ]
机构
[1] Tel Aviv Univ, Sackler Sch Med, Dept Human Genet & Mol Med, IL-69978 Tel Aviv, Israel
关键词
D O I
10.1016/S1471-4914(02)02365-1
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
Replacement of the insulin-producing pancreatic islet beta cells represents the ultimate treatment for type 1 diabetes. Recent advances in islet transplantation underscore the urgent need for developing alternatives to human tissue donors, which are scarce. Two possible approaches are the expansion of differentiated beta cells by reversible immortalization and the generation of insulin-producing cells from embryonic or adult stem cells. It is possible that new insights into endocrine pancreas development will ultimately lead to manipulation of progenitor-cell fate towards the beta-cell phenotype of insulin production, storage and regulated secretion. Both allogeneic and autologous surrogate beta cells are likely to require protection from recurring autoimmunity. This protection might take the form of tolerization, cell encapsulation, or cell engineering with immunoprotective genes. If successful, these approaches could lead to widespread cell replacement therapy for type 1 diabetes.
引用
收藏
页码:334 / 339
页数:6
相关论文
共 44 条
[1]   Insulin production by human embryonic stem cells [J].
Assady, S ;
Maor, G ;
Amit, M ;
Itskovitz-Eldor, J ;
Skorecki, KL ;
Tzukerman, M .
DIABETES, 2001, 50 (08) :1691-1697
[2]   Uncertainty in xenotransplantation: Individual benefit versus collective risk [J].
Bach, FH ;
Fishman, JA ;
Daniels, N ;
Proimos, J ;
Anderson, B ;
Carpenter, CB ;
Forrow, L ;
Robson, SC ;
Fineberg, HV .
NATURE MEDICINE, 1998, 4 (02) :141-144
[3]   Adenovirus-mediated catalase gene transfer reduces oxidant stress in human, porcine and rat pancreatic islets [J].
Benhamou, PY ;
Moriscot, C ;
Richard, MJ ;
Beatrix, O ;
Badet, L ;
Pattou, F ;
Kerr-Conte, J ;
Chroboczek, J ;
Lemarchand, P ;
Halimi, S .
DIABETOLOGIA, 1998, 41 (09) :1093-1100
[4]   In vitro cultivation of human islets from expanded ductal tissue [J].
Bonner-Weir, S ;
Taneja, M ;
Weir, GC ;
Tatarkiewicz, K ;
Song, KH ;
Sharma, A ;
O'Neil, JJ .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 2000, 97 (14) :7999-8004
[5]   Identification of a subpopulation of rapidly self-renewing and multipotential adult stem cells in colonies of human marrow stromal cells [J].
Colter, DC ;
Sekiya, I ;
Prockop, DJ .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 2001, 98 (14) :7841-7845
[6]   Tolerogenic strategies to halt or prevent type I diabetes [J].
Cooke, A ;
Phillips, JM ;
Parish, NM .
NATURE IMMUNOLOGY, 2001, 2 (09) :810-815
[7]   SOCS-1 protein prevents Janus kinase/STAT-dependent inhibition of β cell insulin gene transcription and secretion in response to interferon-γ [J].
Cottet, S ;
Dupraz, P ;
Hamburger, F ;
Dolci, W ;
Jaquet, M ;
Thorens, B .
JOURNAL OF BIOLOGICAL CHEMISTRY, 2001, 276 (28) :25862-25870
[8]  
de la Tour DD, 2001, MOL ENDOCRINOL, V15, P476
[9]   Lentivirus-mediated Bcl-2 expression in βTC-tet cells improves resistance to hypoxia and cytokine-induced apoptosis while preserving in vitro and in vivo control of insulin secretion [J].
Dupraz, P ;
Rinsch, C ;
Pralong, WF ;
Rolland, E ;
Zufferey, R ;
Trono, D ;
Thorens, B .
GENE THERAPY, 1999, 6 (06) :1160-1169
[10]   Dominant negative MyD88 proteins inhibit interleukin-1β/interferon-γ-mediated induction of nuclear factor κB-dependent nitrite production and apoptosis in β cells [J].
Dupraz, P ;
Cottet, S ;
Hamburger, F ;
Dolci, W ;
Felley-Bosco, E ;
Thorens, B .
JOURNAL OF BIOLOGICAL CHEMISTRY, 2000, 275 (48) :37672-37678